CTOs on the Move

Immunicom

www.immunicom.com

 
Immunicom, Inc. is a privately held medical technology company that develops subtractive therapies for cancer, autoimmune disorders, and inflammatory and renal diseases. Immunicom`s blood-filtering Immunopheresis technology has the potential to effectively treat a wide variety of cancer types and other terminal diseases with a safer side-effect profile than conventional treatments. Immunicom`s lead product, the LW-02 column, previously received FDA Breakthrough Device designation in 2018 for stage IV metastatic cancer, and European regulatory clearance (CE Mark certification) in 2021 for use in adults with advanced, refractory, triple negative breast cancer. Immunopheresis is being evaluated in several global oncology trials for multiple ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.immunicom.com
  • 6048 Cornerstone Court West Suite D
    San Diego, CA USA 92121
  • Phone: 657.202.6388

Executives

Name Title Contact Details
Annette Marleau
 Chief Technology Officer Profile

Funding

Immunicom raised $11M on 07/02/2019

Similar Companies

Dendritic NanoTechnologies

Dendritic NanoTechnologies is a Mount Pleasant, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Scilogex

Scilogex is a Berlin, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BillionToOne

BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible. Our proprietary molecular counting platform can accurately count DNA molecules at the single-count level to help improve disease detection.

Synspira

Synspira Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to significantly improving the lives of people with cystic fibrosis (CF) and other rare diseases.

Incellico Inc

Incellico Inc is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.